<?xml version="1.0" encoding="UTF-8"?>
<p>As dengue‐endemic region, some countries in Asia experiencing of overlapping outbreaks of dengue and Covid‐19. This poses a challenge for accurate diagnosis and treatment since both infections share similar symptoms and laboratory features in the early phase. In addition, cross‐reactivity between antibodies against DENV and SARS‐CoV‐2 serology tests have been documented in reports. Therefore, a simple and affordable rapid test capable of differentiating SARS‐CoV‐2 and DENV with high sensitivity, is urgently needed. In addition, there is an urgent need to establish additional laboratories to perform specific RT‐PCR testing for SARS‐CoV‐2 in the region.</p>
